Mycobacterium tuberculosis (Mtb) regulates lung macrophage activation and function, including the balance of pro-inflammatory and anti-inflammatory mechanisms that affect pulmonary immune responses and the outcome of infection. We propose that optimum host response and containment of infection requires proper regulation of the inflammatory balance. Better understanding of this balance and how it is regulated will advance our understanding of how Mtb evades host immunity and the problems of latent infection and disease progression. We propose that factors downstream of Toll-like receptor 2 (TLR2) contribute to regulation of this balance;among these are Tpl2, ERK and KLF4, which we propose promote expression of IL-10, induce other anti- inflammatory mechanisms, and contribute to inhibition of macrophage MHC-II antigen presentation, thereby regulating both innate and adaptive immunity to Mtb. We will study markers of lung macrophage inflammatory state and function;a central paradigm will be the balance of IL-10 and IL-12, which are anti-inflammatory and pro-inflammatory mediators, respectively. We will use knockout and floxed gene models (for cell lineage- specific knockout) to focus studies on lung macrophages, as well as pharmacologic tools, to test the role of Tpl2, ERK and other molecules in regulating the inflammatory balance of lung macrophages during infection with Mtb. We will use both human and mouse models to study regulation of lung or alveolar macrophages.
Aim 1 will determine the roles of TLR2 and other receptors pathways in regulating the ERK pathway and the inflammatory balance of lung macrophages during responses to Mtb.
Aim 2 will determine the roles Tpl2, ERK and downstream mechanisms (e.g. KLF4) in regulating the inflammatory balance of lung macrophages during responses to Mtb.
Aim 3 will determine the roles of Tpl2, ERK1/2 and KLF4 in regulation of macrophages and host immunity in vivo.
These studies will reveal molecules and signaling pathways that control the balance of pro- vs. anti-inflammatory responses during tuberculosis (TB) infection in the lung. Control of the inflammatory balance is critical to the outcome of TB infection and either too much or too little inflammatory response is detrimental. Understanding of these mechanisms will clarify critical control points in immune responses, potential mechanisms for immune suppression and immune evasion, potential novel pathways for immunotherapeutic intervention for Mtb infection, and strategies to manipulate responses to TB vaccines.
|Zhang, Lumin; Luo, Zhenwu; Sieg, Scott F et al. (2014) Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis. J Virol 88:11430-41|
|Shukla, Supriya; Richardson, Edward T; Athman, Jaffre J et al. (2014) Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog 10:e1004471|
|Reba, Scott M; Li, Qing; Onwuzulike, Sophia et al. (2014) TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis. Eur J Immunol 44:1410-21|
|Gabrilovich, M I; Walrath, J; van Lunteren, J et al. (2013) Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 173:512-22|
|Hardy, Gareth A D; Sieg, Scott; Rodriguez, Benigno et al. (2013) Interferon-* is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS One 8:e56527|
|Li, Qing; Ding, Xuedong; Thomas, Jeremy J et al. (2012) Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5. J Leukoc Biol 91:311-20|
|Simmons, Daimon P; Wearsch, Pamela A; Canaday, David H et al. (2012) Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol 188:3116-26|
|Liu, Yi C; Simmons, Daimon P; Li, Xiaoxia et al. (2012) TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9. J Immunol 188:1019-26|
|Mahon, Robert N; Sande, Obondo J; Rojas, Roxana E et al. (2012) Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation. Cell Immunol 275:98-105|
|Lancioni, Christina L; Li, Qing; Thomas, Jeremy J et al. (2011) Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. Infect Immun 79:663-73|
Showing the most recent 10 out of 82 publications